-
-
-
-
-
-
-
BioMarin to acquire Alesta Therapeutics for $275M upfront
-
-
-
-
-
-
-
Goldman Sachs Starts BioMarin Pharmaceutical Inc. (BMRN) at Neutral
-
-
-
-
-
-
-
BioMarin Reports Fourth Quarter and Full-year 2025 Financial and Operating Results
-
-
-
-
-
-
-
Canaccord Genuity Upgrades BioMarin Pharmaceutical Inc. (BMRN) to Buy
-
-
-
-
-
-
-
BioMarin Reports Third Quarter 2025 Results and Provides Corporate Update
-
-
-
-
-
-
-
BioMarin Pharmaceutical Inc. (BMRN) PT Raised at Bernstein Following Inozyme Deal
-
-
-
-
-
-
-
BioMarin Announces Appointment of Timothy P. Walbert to Board of Directors
-
1,192,388 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

